Literature DB >> 2036837

Asthma deaths.

W A Whitelaw1.   

Abstract

Deaths from asthma seem to be increasing in spite of considerable improvements in drug treatment and management plans. There are many hypotheses to explain this, but little emphasis has been placed on the possibility that confidence in better drug treatments may modify patients' behavior so as to place them at greater risk of illness. It is well recognized that excessive confidence in bronchodilator inhalers and nebulizers can make patients stay away from hospitals too long during acute attacks. It is also very possible that prevention of symptoms by use of antiasthma drugs could allow patients to spend more time in environments containing antigens or other agents that provoke asthma, resulting in more serious and long-lasting bronchial inflammation and reactivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036837     DOI: 10.1378/chest.99.6.1507

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  The effects on prescribing patterns and costs of having a special interest in asthma.

Authors:  K P Jones; C M Harris; S M Bogle; R Foley; T P Usherwood
Journal:  J R Soc Med       Date:  1995-10       Impact factor: 5.344

2.  The impact of guidelines on long-term asthma care: a study of hospitalised patients in Malta.

Authors:  Antonella Tonna; Dorothy J McCaig; Joseph M Cacciottolo
Journal:  Pharm World Sci       Date:  2004-08

3.  Impaired voluntary drive to breathe: a possible link between depression and unexplained ventilatory failure in asthmatic patients.

Authors:  G M Allen; I Hickie; S C Gandevia; D K McKenzie
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

Review 4.  The role of airway mucus in pulmonary toxicology.

Authors:  J M Samet; P W Cheng
Journal:  Environ Health Perspect       Date:  1994-06       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.